drugset / Trial / NCT03005496

The Effect of Zinc, β-carotene, and Vitamin D3 in Preterm Delivery Through Placental MyD88, TRIF, NFkB, and IL-1β

NCT03005496

Phase 4 Completed 56 enrolled Indonesia University
Non-randomizedParallel-groupOpen-labelBasic science

Summary

This study is a controlled trial which compares the effect of zinc, beta-carotene, and Vitamin D3 supplementation in pregnant women which has preterm birth. The measured outcome is zinc, vitamin A, and 25(OH)D level in serum and placenta, MyD88, TRIF, NFκB, and IL-1β levels in placenta.

Timeline

Start
2017-01
Primary completion
2017-04
Completion
2017-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Cholecalciferol Other / unclassified 50000 iu Oral
Comparator Zinc Sulfate Unknown 50 mg Oral
Comparator beta-carotene Small molecule 25000 iu Oral
Comparator Dexamethasone Small molecule 6 mg Intravenous
Comparator Nifedipine Other / unclassified 10 mg Oral

Indications

No indication recorded.